[Evidence summary:] What is the risk of severe disease in pregnant patients with COVID-19?
dc.contributor.author | Carrigan, Marie | |
dc.contributor.author | Clark, Helen | |
dc.contributor.author | O'Reilly, Peter | |
dc.contributor.author | Bambury, Niamh | |
dc.contributor.author | Casey, Geraldine | |
dc.contributor.author | Beatty, Kenneth | |
dc.date.accessioned | 2021-08-20T15:11:05Z | |
dc.date.available | 2021-08-20T15:11:05Z | |
dc.date.issued | 2021-08 | |
dc.identifier.uri | http://hdl.handle.net/10147/630146 | |
dc.description | Main Points 1. Pregnancy is regarded as an underlying medical condition which increases a person's risk of developing severe illness. Specific risk factors include maternal age, obesity, non-white ethnicity, pre-existing medical conditions and pregnancy specific disorders such as gestational diabetes and pre-eclampsia. 2. Pregnancy does not increase susceptibility to SARS-COV-2 but can worsen the clinical course of the disease compared to non-pregnant patients of the same age. 3. Pregnant people with COVID-19 have higher rates of ICU admission but are not at increased risk of death from COVID-19. 4. SARS-COV-2 infection at the time of birth can lead to higher rates of foetal death, pre-term birth, preeclampsia and emergency Caesarean section. There were no additional negative neonatal outcomes seen other than those associated with pre-term birth. Risk of transmission of the disease to neonates is low. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Health Service Executive | en_US |
dc.relation.ispartofseries | Q.198 | en_US |
dc.subject | Coronavirus | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | PREGNANCY | en_US |
dc.subject | RISK FACTORS | en_US |
dc.title | [Evidence summary:] What is the risk of severe disease in pregnant patients with COVID-19? | en_US |
dc.type | Other | en_US |
refterms.dateFOA | 2021-08-20T15:11:05Z |
Files in this item
This item appears in the following Collection(s)
-
HSE Library Summaries of Evidence
Evidence summaries and reviews on the management and treatment of Novel Coronavirus Covid-19 and other clinical topics